150 related articles for article (PubMed ID: 35530342)
1. Application of Anlotinib Combined With Neoadjuvant Chemotherapy in Primary EWS/PNET of Lung: A Case Report.
Fan YH; Ma HX; Guo SP; Chen Y; Zhang SP
Front Oncol; 2022; 12():822469. PubMed ID: 35530342
[TBL] [Abstract][Full Text] [Related]
2. Primary EWS/PNET of the lung with TP53 germline and SKT11 somatic mutation: A case report and review of the literature.
Zhang S; Chen Y; Guo S; Chen KN
Thorac Cancer; 2022 Jan; 13(1):137-140. PubMed ID: 34866350
[TBL] [Abstract][Full Text] [Related]
3. Response to chemotherapy combined with anlotinib plus anlotinib maintenance in intra-abdominal desmoplastic small round cell tumors (IADSRCT): a case report and literature review.
Cheng K; Liu X; Chen Y; Zhou K; Li Z
BMC Gastroenterol; 2022 Aug; 22(1):388. PubMed ID: 35978277
[TBL] [Abstract][Full Text] [Related]
4. Pazopanib Confers a Progression-free Survival in a Patient with Ewing's Sarcoma/Primitive Neuroectodermal Tumor of the Lung.
Takigami A; Yamasawa H; Kurosaki A; Sakamoto N; Onuki T; Mato N; Tetsuka K; Endo S; Niki T; Bando M; Hagiwara K
Intern Med; 2019 May; 58(9):1335-1339. PubMed ID: 30626819
[TBL] [Abstract][Full Text] [Related]
5. Primitive neuroectodermal tumor/Ewing's sarcoma in adult uro-oncology: A case series from a developing country.
Mohsin R; Hashmi A; Mubarak M; Sultan G; Shehzad A; Qayum A; Naqvi SA; Rizvi SA
Urol Ann; 2011 May; 3(2):103-7. PubMed ID: 21747604
[TBL] [Abstract][Full Text] [Related]
6. Case Report: Anlotinib Reverses Nivolumab Resistance in Advanced Primary Pulmonary Lymphoepithelioma-Like Carcinoma With FGFR3 Gene Amplification.
Liu Y; Long L; Liu J; Zhu L; Luo F
Front Oncol; 2021; 11():749682. PubMed ID: 34692530
[TBL] [Abstract][Full Text] [Related]
7. Anlotinib Combined With Chemotherapy for Recurrence of Pulmonary Sarcomatoid Cancer Previously Surgically Treated: A Case Report and Literature Review.
Li J; Liang H; He J; Sui X; Qin Y
Front Oncol; 2021; 11():639168. PubMed ID: 34046343
[TBL] [Abstract][Full Text] [Related]
8. Anlotinib combined with chemotherapy and immunotherapy for advanced pulmonary sarcomatoid cancer: a case report and literature review.
Piao MN; Ma XT; Tankere P; Liam CK; Li JL; Wang JP
Ann Transl Med; 2022 Sep; 10(18):1030. PubMed ID: 36267791
[TBL] [Abstract][Full Text] [Related]
9. Efficacy of anlotinib combined with radioiodine to treat scalp metastasis of papillary thyroid cancer: A case report and review of literature.
Zhang LY; Cai SJ; Liang BY; Yan SY; Wang B; Li MY; Zhao WX
World J Clin Cases; 2023 Apr; 11(12):2839-2847. PubMed ID: 37214573
[TBL] [Abstract][Full Text] [Related]
10. Successful treatment of advanced ovarian cancer with anlotinib: a case report.
Zhang P; Ma L; Wang X; Zhang R; Dong Y
J Int Med Res; 2020 Dec; 48(12):300060520976824. PubMed ID: 33284728
[TBL] [Abstract][Full Text] [Related]
11. Switch maintenance therapy with anlotinib after chemotherapy in unresectable or metastatic soft tissue sarcoma: a single-center retrospective study.
Liu J; Deng YT; Jiang Y
Invest New Drugs; 2021 Apr; 39(2):330-336. PubMed ID: 32974853
[TBL] [Abstract][Full Text] [Related]
12. Combined immunotherapy and targeted treatment for primary alveolar soft part sarcoma of the lung: case report and literature review.
Su H; Yu C; Ma X; Song Q
Invest New Drugs; 2021 Oct; 39(5):1411-1418. PubMed ID: 33765213
[TBL] [Abstract][Full Text] [Related]
13. Case Report: Pulmonary sarcomatoid carcinoma complicating TP53 mutation treated successfully with Tislelizumab combined with Anlotinib-a case report.
Li YF; Zhao XF; Tian Y; Xiao XY; Yan CY; Shen H
Front Genet; 2022; 13():949989. PubMed ID: 35938033
[TBL] [Abstract][Full Text] [Related]
14. Anlotinib Combined with S-1 in the Third-Line Treatment of Stage IV Non-Small Cell Lung Cancer: Study Protocol for Phase II Clinical Trial.
Yang X; Xiang M; Geng L; Wen Y; Du X
Asian Pac J Cancer Prev; 2019 Dec; 20(12):3849-3853. PubMed ID: 31870132
[TBL] [Abstract][Full Text] [Related]
15. The real-world efficacy and safety of anlotinib in advanced non-small cell lung cancer.
Wang F; Jin F; Cheng B; Zhang Y; Zhou Q; Wang S
J Cancer Res Clin Oncol; 2022 Jul; 148(7):1721-1735. PubMed ID: 34357411
[TBL] [Abstract][Full Text] [Related]
16. Anlotinib, a novel small molecular tyrosine kinase inhibitor, suppresses growth and metastasis via dual blockade of VEGFR2 and MET in osteosarcoma.
Wang G; Sun M; Jiang Y; Zhang T; Sun W; Wang H; Yin F; Wang Z; Sang W; Xu J; Mao M; Zuo D; Zhou Z; Wang C; Fu Z; Wang Z; Duan Z; Hua Y; Cai Z
Int J Cancer; 2019 Aug; 145(4):979-993. PubMed ID: 30719715
[TBL] [Abstract][Full Text] [Related]
17. Use of anlotinib in intra-abdominal desmoplastic small round cell tumors: a case report and literature review.
Chen HM; Feng G
Onco Targets Ther; 2019; 12():57-61. PubMed ID: 30588030
[TBL] [Abstract][Full Text] [Related]
18. Application of neoadjuvant chemotherapy combined with anlotinib in occult breast cancer: A case report and review of literature.
Zhang Y; Wu D; Zhao B; Tian XL; Yao TC; Li F; Liu WF; Shi AP
World J Clin Cases; 2021 Feb; 9(4):919-926. PubMed ID: 33585640
[TBL] [Abstract][Full Text] [Related]
19. The Efficacy and Safety of Anlotinib in Neoadjuvant Treatment of Locally Advanced Thyroid Cancer: A Single-Arm Phase II Clinical Trial.
Huang NS; Wei WJ; Xiang J; Chen JY; Guan Q; Lu ZW; Ma B; Sun GH; Wang YL; Ji QH; Wang Y
Thyroid; 2021 Dec; 31(12):1808-1813. PubMed ID: 34610756
[No Abstract] [Full Text] [Related]
20. Primary Renal Primitive Neuroectodermal Tumor/Ewing's Sarcoma Imaging and Pathologic Findings of a Patient with a Nine Year, Eight Month Disease Free Period: Case Report and Review of Literature.
Zokalj I; Igrec J; Plesnar A
Nephrourol Mon; 2016 Jul; 8(4):e37950. PubMed ID: 27703957
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
